Title : Molecular Characteristics of the Uncommon EGFR Exon 21 T854A Mutation and Response to Osimertinib in Patients With Non-Small Cell Lung Cancer.

Pub. Date : 2022 Jun

PMID : 35045945






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Moreover, EGFR C797S mutation was detected in 1 patient after resistant to osimertinib treatment. osimertinib epidermal growth factor receptor Homo sapiens
2 CONCLUSION: Presence of EGFR T854A mutation was rare in NSCLC patients and our retrospective study provides clinical evidence that osimertinib may be an effective treatment to improve survival outcomes in patients with EGFR T854A. osimertinib epidermal growth factor receptor Homo sapiens
3 CONCLUSION: Presence of EGFR T854A mutation was rare in NSCLC patients and our retrospective study provides clinical evidence that osimertinib may be an effective treatment to improve survival outcomes in patients with EGFR T854A. osimertinib epidermal growth factor receptor Homo sapiens